Markets › India › NSE › STAR

Strides Pharma Science Ltd

NSE:STARHealthcareNSE:NIFTY_MICROCAP250NSE:NIFTY_TOTAL_MKT

₹1,029.30−1.52%At closeAt close · Mon 19 Oct · ≈ AED 39.71 · Market cap $1.01B · Next earnings Thu 29 Oct

Ratio	FY2021	FY2022	FY2023	FY2024	FY2025	FY2026	Current · undated	YoY
Gross margin	29.2%	13.4%	21.9%	22.2%	26.4%	36.4%	—	—
Operating margin	9.6%	−8.2%	3.4%	7.9%	11.6%	14.9%	14.9%	+0.0 pts
Net margin	7.8%	−15.0%	−6.0%	−3.1%	9.1%	11.4%	11.4%	+0.0 pts
EBITDA margin	15.8%	−8.0%	5.9%	9.9%	20.7%	21.6%	—	—
Return on equity	9.2%	−19.5%	−10.0%	−5.7%	15.9%	17.9%	17.7%	−0.2 pts
Return on assets	3.6%	−6.6%	−3.3%	−2.1%	6.7%	8.0%	8.0%	+0.0 pts
Return on capital employed	7.4%	−7.1%	3.4%	10.2%	15.0%	17.9%	—	—
Debt / equity	0.8×	1.3×	1.4×	1.2×	0.7×	0.6×	0.6×	−1.3%
Debt / assets	33.5%	43.4%	45.6%	43.1%	31.1%	25.4%	—	—
Interest coverage	2.1×	−1.4×	0.5×	1.1×	2.1×	4.0×	—	—
Current ratio	1.0×	1.0×	1.1×	1.0×	1.2×	1.2×	1.2×	+0.0%
Quick ratio	0.6×	0.6×	0.7×	0.6×	0.7×	0.7×	—	—
Cash ratio	0.0×	0.1×	0.1×	0.1×	0.1×	0.1×	0.1×	+0.0%
Asset turnover	0.5×	0.4×	0.6×	0.7×	0.7×	0.7×	—	—
Inventory turnover	1.9×	2.3×	2.5×	2.6×	2.6×	1.9×	—	—
Receivables turnover	2.9×	1.7×	2.6×	3.4×	3.7×	3.7×	—	—
Dividend payout	7.0%	−4.9%	0.0%	−11.2%	5.7%	6.6%	—	—